Overview
Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy
Status:
Unknown status
Unknown status
Trial end date:
2017-10-01
2017-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study was to evaluate efficacy and safety of dexmedetomidine infusion during laparoscopic cholecystectomy. The randomized, single-center, controlled study was carried out from May 2016 to June 2017 at department of surgery, anesthesiology and intensive care, Postgraduate Institute of Bogomolets National Medical University.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bogomolets National Medical UniversityTreatments:
Analgesics
Dexmedetomidine
Criteria
Inclusion Criteria:- patients elected for laparoscopic cholecystectomy
- age between 18 and 79 years
- either sex
- ASA physical status I to II
Exclusion Criteria:
- age outside the specified range
- pregnancy or lactation
- severe systemic disease (ASA III physical status or more)
- patients on b-blockers or calcium channel blockers